Answers are grounded in this paper and cite their sources.
Material extrusion (MEX) of high-performance polymers typically yields lower dimensional performance than subtractive manufacturing, thereby limiting clinical applications. This study systematically compared MEX across polyaryletherketone (PAEK) variants, including polyetheretherketone (PEEK), polyetherketoneketone (PEKK), and CFR-PEEK, with subtractive milling and manual casting, using identical patient-specific cranial geometries. CFR-PEEK MEX achieved manufacturing reproducibility of 0.09 ± 0.05 mm root-mean-square error (RMSE), outperforming milled PEEK at 0.16 ± 0.05 mm ( p < 0.01), with fiber reinforcement suppressing edge-localized thermal distortion and achieving ± 0.3 mm spatial uniformity across 95 % of complex surfaces. PEKK MEX demonstrated 57 % higher manufacturing reproducibility than PEEK MEX (0.21 ± 0.05 mm versus 0.49 ± 0.02 mm RMSE), attributable to narrower thermal processing windows and higher glass transition temperature. Quasi-static biomechanical testing revealed controlled linear fractures at layer interfaces in MEX materials, with PEKK MEX maintaining structural integrity beyond 10 mm displacement (>1500 N), in contrast to the brittle stellate fragmentation observed in cast PMMA. All manufacturing methods met clinically acceptable dimensional thresholds for cranial reconstruction, demonstrating that point-of-care composite CFR-PEEK MEX can achieve dimensional performance comparable to established subtractive manufacturing workflows.
No takes yet. Share an insight, caveat, or question.
Sharma et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: